Roleof Allogeneic Stem Cell Transplant (ASCT) in Patients (Pts) with Relapsed/Refractory (R-R) Acute Lymphoblastic Leukemia (ALL) Treated with Inotuzumab Ozogamicin (INO) in Combination with Low-Intensity Chemotherapy (mini-hyper-CVD) with or without Blinatumomab (Blina): Results from a Phase 2 Study

Hind Rafei,Jeffrey L Jorgensen,Partow Kebriaei,Marina Konopleva,Koji Sasaki,William G Wierda,Courtney D Dinardo,Jovitta Jacob,Ghayas C Issa,Meagan Rostykus,Patrice Nasnas,Rebecca Garris,Nadya Jammal,Hagop M Kantarjian,Issa F Khouri,Nitin Jain,Xuelin Huang,Farhad Ravandi,Bouthaina S Dabaja,Tapan M Kadia,Richard E Champlin,Joseph D Khoury,Elias Jabbour,Rita Khouri,Naveen Pemmaraju,Susan O’brien ,Nicholas J Short ,Paul Stolzmann ,Sa A Wang ,Guillermo Garcia‐Manero ,Naval Daver ,Philip A Thompson ,Guillermo Montalban‐Bravo

doi:10.1182/blood-2020-143286

Roleof Allogeneic Stem Cell Transplant (ASCT) in Patients (Pts) with Relapsed/Refractory (R-R) Acute Lymphoblastic Leukemia (ALL) Treated with Inotuzumab Ozogamicin (INO) in Combination with Low-Intensity Chemotherapy (mini-hyper-CVD) with or without Blinatumomab (Blina): Results from a Phase 2 Study

Hind Rafei, Jeffrey L Jorgensen + Show 31 more

Open Access

https://doi.org/10.1182/blood-2020-143286

Copy DOI

Journal: Blood

Publication Date: Nov 5, 2020

Affiliation: The University of Texas MD Anderson Cancer Center, University of California, Irvine Medical Center

#Research Funding #Advisory Committees + Show 8 more

Abstract
Full-Text
Similar Papers

Abstract

Roleof Allogeneic Stem Cell Transplant (ASCT) in Patients (Pts) with Relapsed/Refractory (R-R) Acute Lymphoblastic Leukemia (ALL) Treated with Inotuzumab Ozogamicin (INO) in Combination with Low-Intensity Chemotherapy (mini-hyper-CVD) with or without Blinatumomab (Blina): Results from a Phase 2 Study

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Blood

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.